[68Ga]Ga-DOTA.SA.FAPi与[18F]F-FDG PET/CT在肉瘤患者中的头对头比较
纳入23例经组织学确诊的肉瘤患者,均行[68Ga]Ga-DOTA.SA.FAPi与[18F]F-FDG PET/CT检查,按患者和病灶分别比较。原发瘤与淋巴结检出率两组差异未达统计学显著;病灶分析中[18F]F-FDG总体检出效率更高,而[68Ga]Ga-DOTA.SA.FAPi在肝转移(54 vs 38个病灶,P<0.0001)和骨转移(125 vs 102个病灶,P<0.0001)检出更多。作者认为两种显像在肉瘤评估中具有互补作用。
要点
- 23例肉瘤患者中,原发瘤检出率85.7% vs 100%(P=0.149),淋巴结80% vs 100%(P=0.146)。
- 病灶分析:[68Ga]Ga-DOTA.SA.FAPi检出220个病灶(83%),[18F]F-FDG检出249个(94%),P<0.0001。
- 作者认为两种显像在肉瘤评估中互补。
核心结论
- 作者认为,[18F]F-FDG PET/CT总体病灶检出效率更优,而[68Ga]Ga-DOTA.SA.FAPi PET/CT在识别特定转移部位(尤其骨和肝)方面更突出,两者在肉瘤评估中具有互补作用。
研究设计与样本
- 本研究为头对头比较,纳入经组织学确诊的肉瘤患者,对PET/CT扫描结果分别进行基于患者和基于病灶的分析。
主要发现
- 共23例肉瘤患者(平均年龄43.0 ± 16.5岁;范围21~76岁)接受[18F]F-FDG与[68Ga]Ga-DOTA.SA.FAPi PET/CT两种扫描,组织学分布包括30%滑膜肉瘤、13%脂肪肉瘤、21.7%平滑肌肉瘤,70%患者存在远处转移。
- 原发瘤检出率[68Ga]Ga-DOTA.SA.FAPi与[18F]F-FDG PET/CT相近(85.7% vs 100%,P=0.149),淋巴结检出率亦相近(80% vs 100%,P=0.146)。
- 基于病灶分析,[68Ga]Ga-DOTA.SA.FAPi检出220个病灶(效率83%),[18F]F-FDG检出249个病灶(效率94%),P<0.0001。
- [68Ga]Ga-DOTA.SA.FAPi对肝转移(54 vs 38个病灶,P<0.0001)和骨转移(125 vs 102个病灶,P<0.0001)的检出优于[18F]F-FDG。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to compare the diagnostic efficacy of [ 68 Ga]Ga-DOTA.SA.FAPi and [ 18 F]F-FDG PET/CT for detecting primary and metastatic lesions in sarcoma patients. MATERIALS AND METHODS: The analysis included both patient-based and lesion-based comparisons of PET/CT scans in individuals with histologically confirmed sarcoma. RESULTS: A total of 23 sarcoma patients (mean age 43.0 ± 16.5 years; range: 21-76 years) underwent both [ 18 F]F-FDG and [ 68 Ga]Ga-DOTA.SA.FAPi PET/CT scans. Histological distribution included 30% synovial sarcoma, 13% liposarcoma, and 21.7% leiomyosarcoma, with 70% of patients presenting with distant metastases. Detection rates for primary tumors were similar between [ 68 Ga]Ga-DOTA.SA.FAPi and [ 18 F]F-FDG PET/CT (85.7% vs 100%, P = 0.149). Lymph node detection rates were also comparable (80% vs 100%, P = 0.146). Lesion-based analysis revealed that [ 68 Ga]Ga-DOTA.SA.FAPi detected 220 lesions (83% efficiency) compared with 249 lesions (94% efficiency) for [ 18 F]F-FDG ( P < 0.0001). Notably, [ 68 Ga]Ga-DOTA.SA.FAPi demonstrated superior detection of liver (54 vs 38 lesions, P < 0.0001) and bone metastases (125 vs 102 lesions, P < 0.0001). CONCLUSIONS: Our study shows that although [ 18 F]F-FDG PET/CT offers superior overall lesion detection efficiency, [ 68 Ga]Ga-DOTA.SA.FAPi PET/CT excels in identifying specific metastatic sites, particularly in bone and liver. These findings highlight the complementary roles of both imaging modalities in sarcoma evaluation.
引用
- Sakir M, Ballal S, Rastogi S, et al. Head-to-Head Comparison Between [ 68 Ga]Ga-DOTA.SA.FAPi And [ 18 F]F-FDG PET/CT Imaging in Patients With Sarcoma. Clin Nucl Med. 2025. PMID: 39876086. doi:10.1097/RLU.0000000000005697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。